Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

FRA:6D81 - Deutsche Boerse Ag - US26614N1028 - Common Stock - Currency: EUR

57.68  +0.19 (+0.33%)

Fundamental Rating

5

Taking everything into account, 6D81 scores 5 out of 10 in our fundamental rating. 6D81 was compared to 61 industry peers in the Chemicals industry. 6D81 scores excellent on profitability, but there are some minor concerns on its financial health. 6D81 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

6D81 had positive earnings in the past year.
In the past year 6D81 had a positive cash flow from operations.
Of the past 5 years 6D81 4 years were profitable.
Each year in the past 5 years 6D81 had a positive operating cash flow.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

6D81's Return On Assets of 1.92% is fine compared to the rest of the industry. 6D81 outperforms 62.30% of its industry peers.
6D81 has a better Return On Equity (3.01%) than 60.66% of its industry peers.
6D81 has a better Return On Invested Capital (3.85%) than 63.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 6D81 is below the industry average of 6.81%.
The 3 year average ROIC (3.52%) for 6D81 is below the current ROIC(3.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.92%
ROE 3.01%
ROIC 3.85%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

6D81 has a better Profit Margin (5.68%) than 72.13% of its industry peers.
6D81's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.15%, 6D81 belongs to the top of the industry, outperforming 85.25% of the companies in the same industry.
6D81's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 36.59%, 6D81 perfoms like the industry average, outperforming 55.74% of the companies in the same industry.
6D81's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.15%
PM (TTM) 5.68%
GM 36.59%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 6D81 is destroying value.
Compared to 1 year ago, 6D81 has less shares outstanding
Compared to 5 years ago, 6D81 has less shares outstanding
The debt/assets ratio for 6D81 has been reduced compared to a year ago.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

6D81 has an Altman-Z score of 0.91. This is a bad value and indicates that 6D81 is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 6D81 (0.91) is worse than 75.41% of its industry peers.
The Debt to FCF ratio of 6D81 is 5.66, which is a neutral value as it means it would take 6D81, 5.66 years of fcf income to pay off all of its debts.
6D81's Debt to FCF ratio of 5.66 is fine compared to the rest of the industry. 6D81 outperforms 68.85% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that 6D81 is not too dependend on debt financing.
The Debt to Equity ratio of 6D81 (0.23) is better than 72.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.66
Altman-Z 0.91
ROIC/WACC0.47
WACC8.16%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

6D81 has a Current Ratio of 1.33. This is a normal value and indicates that 6D81 is financially healthy and should not expect problems in meeting its short term obligations.
6D81 has a Current ratio of 1.33. This is in the lower half of the industry: 6D81 underperforms 68.85% of its industry peers.
6D81 has a Quick Ratio of 1.33. This is a bad value and indicates that 6D81 is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.88, 6D81 is doing worse than 62.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.88
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

6D81 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.95%, which is quite good.
The Earnings Per Share has been decreasing by -5.50% on average over the past years.
Looking at the last year, 6D81 shows a small growth in Revenue. The Revenue has grown by 2.64% in the last year.
Measured over the past years, 6D81 shows a decrease in Revenue. The Revenue has been decreasing by -4.31% on average per year.
EPS 1Y (TTM)16.95%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%29.89%
Revenue 1Y (TTM)2.64%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%6.69%

3.2 Future

The Earnings Per Share is expected to grow by 11.40% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.31% on average over the next years.
EPS Next Y8.35%
EPS Next 2Y9.15%
EPS Next 3Y10%
EPS Next 5Y11.4%
Revenue Next Year3.07%
Revenue Next 2Y3.8%
Revenue Next 3Y4.44%
Revenue Next 5Y5.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.11, which indicates a correct valuation of 6D81.
Compared to the rest of the industry, the Price/Earnings ratio of 6D81 indicates a somewhat cheap valuation: 6D81 is cheaper than 73.77% of the companies listed in the same industry.
6D81's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.79.
The Price/Forward Earnings ratio is 14.85, which indicates a correct valuation of 6D81.
6D81's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 6D81 is cheaper than 70.49% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, 6D81 is valued a bit cheaper.
Industry RankSector Rank
PE 16.11
Fwd PE 14.85
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

6D81's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, 6D81 is valued a bit cheaper than 65.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.62
EV/EBITDA 10.66
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 6D81 may justify a higher PE ratio.
PEG (NY)1.93
PEG (5Y)N/A
EPS Next 2Y9.15%
EPS Next 3Y10%

2

5. Dividend

5.1 Amount

6D81 has a Yearly Dividend Yield of 2.48%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of 6D81 has falen by -22.11%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
6D81's Dividend Yield is comparable with the industry average which is at 3.19.
Compared to an average S&P500 Dividend Yield of 2.47, 6D81 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.48%

5.2 History

The dividend of 6D81 decreases each year by -33.98%.
Dividend Growth(5Y)-33.98%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

6D81 pays out 90.33% of its income as dividend. This is not a sustainable payout ratio.
DP90.33%
EPS Next 2Y9.15%
EPS Next 3Y10%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B
6D81.DE Dividend Payout.6D81.DE Dividend Payout, showing the Payout Ratio.6D81.DE Dividend Payout.PayoutRetained Earnings

DUPONT DE NEMOURS INC

FRA:6D81 (4/25/2025, 7:00:00 PM)

57.68

+0.19 (+0.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-11 2025-02-11/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners72.82%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap24.14B
Analysts80.74
Price Target78.29 (35.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.48%
Yearly Dividend1.32
Dividend Growth(5Y)-33.98%
DP90.33%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.65%
Min EPS beat(2)11.31%
Max EPS beat(2)11.99%
EPS beat(4)4
Avg EPS beat(4)13.12%
Min EPS beat(4)10.57%
Max EPS beat(4)18.61%
EPS beat(8)6
Avg EPS beat(8)7.43%
EPS beat(12)10
Avg EPS beat(12)8.62%
EPS beat(16)14
Avg EPS beat(16)8.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-2.15%
Revenue beat(4)2
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)1.17%
Revenue beat(8)2
Avg Revenue beat(8)-1.76%
Revenue beat(12)3
Avg Revenue beat(12)-1.49%
Revenue beat(16)3
Avg Revenue beat(16)-7.04%
PT rev (1m)-18.97%
PT rev (3m)-19.66%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)-1.64%
EPS NY rev (1m)-2.12%
EPS NY rev (3m)-2.59%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-1.72%
Revenue NY rev (1m)-0.86%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE 16.11
Fwd PE 14.85
P/S 2.21
P/FCF 21.62
P/OCF 14.84
P/B 1.17
P/tB 19.4
EV/EBITDA 10.66
EPS(TTM)3.58
EY6.21%
EPS(NY)3.88
Fwd EY6.73%
FCF(TTM)2.67
FCFY4.63%
OCF(TTM)3.89
OCFY6.74%
SpS26.06
BVpS49.13
TBVpS2.97
PEG (NY)1.93
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 3.01%
ROCE 5.89%
ROIC 3.85%
ROICexc 4.08%
ROICexgc 15.21%
OM 15.15%
PM (TTM) 5.68%
GM 36.59%
FCFM 10.24%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
ROICexc(3y)3.85%
ROICexc(5y)3.28%
ROICexgc(3y)12.84%
ROICexgc(5y)9.92%
ROCE(3y)5.39%
ROCE(5y)4.66%
ROICexcg growth 3Y25.22%
ROICexcg growth 5Y11.83%
ROICexc growth 3Y9.23%
ROICexc growth 5Y14.61%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.66
Debt/EBITDA 1.73
Cap/Depr 48.49%
Cap/Sales 4.67%
Interest Coverage 4.76
Cash Conversion 60.16%
Profit Quality 180.37%
Current Ratio 1.33
Quick Ratio 0.88
Altman-Z 0.91
F-Score8
WACC8.16%
ROIC/WACC0.47
Cap/Depr(3y)55.14%
Cap/Depr(5y)53.03%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.95%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%29.89%
EPS Next Y8.35%
EPS Next 2Y9.15%
EPS Next 3Y10%
EPS Next 5Y11.4%
Revenue 1Y (TTM)2.64%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%6.69%
Revenue Next Year3.07%
Revenue Next 2Y3.8%
Revenue Next 3Y4.44%
Revenue Next 5Y5.31%
EBIT growth 1Y8.63%
EBIT growth 3Y0.11%
EBIT growth 5Y-0.66%
EBIT Next Year32.55%
EBIT Next 3Y15.26%
EBIT Next 5Y13.76%
FCF growth 1Y-2.39%
FCF growth 3Y-3.02%
FCF growth 5YN/A
OCF growth 1Y-3.7%
OCF growth 3Y-6.79%
OCF growth 5Y5.56%